ICU Medical (NASDAQ:ICUI) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

ICU Medical, Inc. (NASDAQ:ICUI)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $157.00 and traded as high as $162.01. ICU Medical shares last traded at $160.99, with a volume of 133,187 shares.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday, December 11th. Finally, KeyCorp boosted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, ICU Medical presently has a consensus rating of “Moderate Buy” and an average price target of $199.67.

ICU Medical Stock Performance

The firm’s fifty day moving average price is $163.34 and its 200-day moving average price is $157.00. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The company has a market cap of $3.78 billion, a P/E ratio of -33.77 and a beta of 0.63.

Insider Activity at ICU Medical

In other news, CEO Vivek Jain sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, November 1st. The stock was sold at an average price of $171.84, for a total value of $2,062,080.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at $17,973,261.12. This trade represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Christian B. Voigtlander sold 1,962 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The disclosure for this sale can be found here. Insiders have sold 29,737 shares of company stock worth $4,941,832 in the last ninety days. Company insiders own 6.70% of the company’s stock.

Hedge Funds Weigh In On ICU Medical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Rhumbline Advisers boosted its position in ICU Medical by 23.0% during the 2nd quarter. Rhumbline Advisers now owns 66,916 shares of the medical instruments supplier’s stock worth $7,946,000 after buying an additional 12,519 shares during the period. Victory Capital Management Inc. lifted its stake in ICU Medical by 2,966.3% during the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock valued at $16,844,000 after acquiring an additional 137,222 shares in the last quarter. Arizona State Retirement System grew its position in ICU Medical by 7.9% in the 2nd quarter. Arizona State Retirement System now owns 6,082 shares of the medical instruments supplier’s stock worth $722,000 after purchasing an additional 443 shares in the last quarter. Savant Capital LLC bought a new position in shares of ICU Medical in the second quarter valued at approximately $431,000. Finally, Choreo LLC bought a new stake in shares of ICU Medical during the 2nd quarter worth $313,000. 96.10% of the stock is owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.